title: 2B4 functions as a co-receptor in human NK cell activation.
abstract: Natural cytotoxicity receptors (NKp46, NKp44 and NKp300) play a predominant role in human NK cell triggering during natural cytotoxicity. Human 2B4 also induced NK cell activation in redirected killing assays using anti-2B4 monoclonal antibodies (mAb) and murine targets. Since this effect was confined to a fraction of NK cells, this suggested a functional heterogeneity of 2B4 molecules. Here we show that activation via 2B4 in redirected killing against murine targets is strictly dependent upon the engagement of NKp46 by murine ligand (s) on target cells. Thus, NK cell clones expressing high surface density of NKp46 (NKp46bright) were triggered by anti-2B4 mAb, whereas NKp46dull clones were not although they expressed a comparable surface density of 2B4. mAb-mediated modulation of NKp46 molecules in NKp46bright clones had no effect on the expression of 2B4 while it rendered cells unresponsive to anti-2B4 mAb. Finally, anti-2B4 mAb could induce NK cell triggering in NKp46dull clones provided that suboptimal doses of anti-NKp44 or anti-CD16 mAb were added to the redirected killing assay. These results indicate that differences in responses do not reflect a functional heterogeneity of 2B4 but rather depend on the co-engagement of triggering receptors.
authors.affiliation: Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Sivori
authors.forename: S
authors.initials: S
authors.lastname: Parolini
authors.forename: M
authors.initials: M
authors.lastname: Falco
authors.forename: E
authors.initials: E
authors.lastname: Marcenaro
authors.forename: R
authors.initials: R
authors.lastname: Biassoni
authors.forename: C
authors.initials: C
authors.lastname: Bottino
authors.forename: L
authors.initials: L
authors.lastname: Moretta
authors.forename: A
authors.initials: A
authors.lastname: Moretta
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D015703:Antigens, CD; D001483:Base Sequence; D019556:COS Cells; D002462:Cell Membrane / Q000276:immunology; D002999:Clone Cells; D003432:Cross-Linking Reagents; D003602:Cytotoxicity, Immunologic; D017931:DNA Primers / Q000235:genetics; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D055627:Natural Cytotoxicity Triggering Receptor 1; D055629:Natural Cytotoxicity Triggering Receptor 2; D017452:Receptors, IgG / Q000378:metabolism; D011971:Receptors, Immunologic / Q000378:metabolism*; D000071176:Signaling Lymphocytic Activation Molecule Family; D014162:Transfection
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C084093:CD244 protein, human; C490007:Cd244a protein, mouse; D003432:Cross-Linking Reagents; D017931:DNA Primers; D008562:Membrane Glycoproteins; C112260:NCR1 protein, human; C112837:NCR2 protein, human; D055627:Natural Cytotoxicity Triggering Receptor 1; D055629:Natural Cytotoxicity Triggering Receptor 2; D017452:Receptors, IgG; D011971:Receptors, Immunologic; D000071176:Signaling Lymphocytic Activation Molecule Family